ADC Therapeutics SA
NYSE:ADCT
3.1 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 278.598 | 326.441 | 466.544 | 439.195 | 115.551 | 138.807 | 262.752 | 143.669 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 278.598 | 326.441 | 466.544 | 439.195 | 115.551 | 138.807 | 262.752 | 143.669 |
| Net Receivables
| 25.182 | 77.714 | 30.218 | 3.1 | 2.84 | 1.889 | 2.028 | 5.908 |
| Inventory
| 16.177 | 18.564 | 11.122 | 6.499 | 2.472 | 1.204 | 0.293 | 0 |
| Other Current Assets
| 16.334 | 28.039 | 17.298 | 1.656 | 1.743 | 0.18 | 0.101 | 1.676 |
| Total Current Assets
| 336.291 | 446.015 | 525.182 | 450.45 | 122.606 | 142.08 | 265.174 | 151.253 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 16.133 | 9.981 | 11.23 | 4.758 | 6.274 | 1.54 | 1.142 | 0.777 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 14.36 | 13.582 | 10.179 | 8.434 | 6.674 | 5.401 | 2.913 |
| Goodwill and Intangible Assets
| 0 | 14.36 | 13.582 | 10.179 | 8.434 | 6.674 | 5.401 | 2.913 |
| Long Term Investments
| 1.647 | 31.152 | 41.236 | 47.908 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 26.757 | 26.049 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.711 | 0.903 | 0.693 | 0.397 | 0.368 | 0.264 | 0.232 | 0.134 |
| Total Non-Current Assets
| 18.491 | 83.153 | 92.79 | 63.242 | 15.076 | 8.478 | 6.775 | 3.824 |
| Total Assets
| 354.782 | 529.168 | 617.972 | 513.692 | 137.682 | 150.558 | 271.949 | 155.077 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 15.569 | 12.351 | 12.08 | 5.279 | 3.329 | 6.75 | 7.619 | 2.145 |
| Short Term Debt
| 1.467 | 13.571 | 7.604 | 4.633 | 1.132 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 3.754 | 0.149 | 0.052 | 0.204 | 0.202 | 0.265 |
| Deferred Revenue
| 0 | 0 | 3.754 | 0.149 | 0 | 1.765 | 2.32 | 1.843 |
| Other Current Liabilities
| 50.634 | 73.035 | 50.497 | 30.375 | 15.482 | 13.839 | 10.608 | 5.68 |
| Total Current Liabilities
| 67.67 | 98.957 | 73.935 | 40.436 | 19.943 | 22.354 | 20.547 | 9.668 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 112.73 | 103.804 | 94.147 | 37.24 | 3.899 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 303.572 | 23.539 | 23.539 | 23.539 | 0 | 0.575 | 1.16 | 3.44 |
| Deferred Tax Liabilities Non-Current
| 10.18 | 0 | 0 | 76.751 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 8.879 | 214.141 | 260.263 | 0.221 | 2.684 | 1.386 | 1.076 | 1.075 |
| Total Non-Current Liabilities
| 435.361 | 341.484 | 377.949 | 137.751 | 6.583 | 1.961 | 2.236 | 4.515 |
| Total Liabilities
| 503.031 | 440.441 | 451.884 | 178.187 | 26.526 | 24.315 | 22.783 | 14.183 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 7.312 | 7.312 | 6.445 | 6.314 | 4.361 | 0.401 | 0.397 | 0.334 |
| Retained Earnings
| -1,335.472 | -1,080.685 | -924.885 | -694.859 | -448.569 | -332.085 | -208.989 | -119.127 |
| Accumulated Other Comprehensive Income/Loss
| -0.093 | 155.327 | 102.829 | 42.998 | 5.542 | 5.659 | 5.462 | 4.567 |
| Other Total Stockholders Equity
| 1,180.004 | 1,006.773 | 981.699 | 981.052 | 549.822 | 452.268 | 452.296 | 255.12 |
| Total Shareholders Equity
| -148.249 | 88.727 | 166.088 | 335.505 | 111.156 | 126.243 | 249.166 | 140.894 |
| Total Equity
| -148.249 | 88.727 | 166.088 | 335.505 | 111.156 | 126.243 | 249.166 | 140.894 |
| Total Liabilities & Shareholders Equity
| 354.782 | 529.168 | 617.972 | 513.692 | 137.682 | 150.558 | 271.949 | 155.077 |